Furthermore, another study indicated that oral supplementation of Tranilast (analog of a metabolite of tryptophan) suppressed the production of TGF-β2 but not TGF-β1 in the experimental glioma model (Prud'Homme 2007; Platten et al., 2001). Here, TGFB2 is linked to central nervous system cancer.